Daphne Karydas is a director of Compass Pathways Plc.
Person profile
Roles
Address
Waltham, Massachusetts
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
COMPASS Pathways plc
20 Sep 23
3
COMPASS Pathways plc
20 Sep 23
3
Mineralys Therapeutics, Inc.
14 Sep 23
4
Mineralys Therapeutics, Inc.
14 Sep 23
4
LogicBio Therapeutics, Inc.
17 Nov 22
4
LogicBio Therapeutics, Inc.
5 Jul 22
4
LogicBio Therapeutics, Inc.
14 Jun 21
4
Syndax Pharmaceuticals Inc
5 Feb 21
4
LogicBio Therapeutics, Inc.
14 Dec 20
3
LogicBio Therapeutics, Inc.
14 Dec 20
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
18 Sep 23 | CMPS Compass Pathways | Share Option Ordinary Shares | Grant | Acquire A | No | No | 9.07 | 52,000 | 471.64 k | 52,000 |
13 Sep 23 | MLYS Mineralys Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 12.02 | 44,000 | 528.88 k | 44,000 |
16 Nov 22 | LOGC LogicBio Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 0.38 | 12,500 | 4.75 k | 0 |